Sun Pharma has completed a 12 weeks trial of its psoriasis drug, MK 3222, but needs 52-124 weeks data to apply for a license with the US FDA, says Surajit Pal, pharma analyst at Prabhudas Lilladher.
first published: May 5, 2016 10:33 am
A collection of the most-viewed Moneycontrol videos.
Realty, PSU Banks Lead Nifty Back Near 25,800; Shriram Finance Scales Record High| Closing Bell Live
Will D-Street See A Sweet Start To November? Autos In Focus After Record Sales| Opening Bell Live
The Sikkim Girl Trying to Make it Big in Mumbai | Tenant
Live: Nifty snaps 4-week gains, slips below 25,800 | Closing Bell
